Creative Medical Tech Files Definitive Proxy Statement
Ticker: CELZ · Form: DEF 14A · Filed: Nov 4, 2024 · CIK: 1187953
Sentiment: neutral
Topics: proxy-statement, regulatory-filing
Related Tickers: CELZ
TL;DR
CREATIVE MEDICAL TECHNOLOGY HOLDINGS (CELZ) filed its proxy statement for the 2024 fiscal year. Standard stuff.
AI Summary
Creative Medical Technology Holdings, Inc. filed an amendment to its Schedule 14A on November 4, 2024, for its definitive proxy statement. The company, previously known as Jolley Marketing Inc. until September 10, 2002, is incorporated in Nevada and has its principal executive offices in Phoenix, Arizona. The filing pertains to the fiscal year ending December 31, 2024.
Why It Matters
This filing is a standard regulatory requirement for public companies, providing shareholders with information necessary to vote on company matters at their annual meeting.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new financial performance data or strategic announcements that would typically impact risk.
Key Players & Entities
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (company) — Registrant
- JOLLEY MARKETING INC (company) — Former company name
- 20241104 (date) — Filing date
- 20241219 (date) — Period of report
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a definitive proxy statement, is filed by a company to provide shareholders with information they need to vote on matters at a shareholder meeting, such as the election of directors or executive compensation.
When was Creative Medical Technology Holdings, Inc. previously known by another name?
The company was formerly known as JOLLEY MARKETING INC until September 10, 2002.
Where are the principal executive offices of Creative Medical Technology Holdings, Inc. located?
The principal executive offices are located at 211 E. Osborn Rd., Phoenix, AZ 85012.
What is the fiscal year end for Creative Medical Technology Holdings, Inc.?
The fiscal year end for the company is December 31.
What is the SIC code for Creative Medical Technology Holdings, Inc.?
The Standard Industrial Classification (SIC) code for the company is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 4,873 words · 19 min read · ~16 pages · Grade level 13.7 · Accepted 2024-11-04 16:01:14
Key Financial Figures
- $8,000 — n firm, to solicit proxies for a fee of $8,000 plus a reasonable amount to cover out-o
- $4.42 — hares of our Common Stock at a price of $4.42 per share (the "Investor Warrants") tha
Filing Documents
- celz_def14a.htm (DEF 14A) — 114KB
- celz_def14aimg10.jpg (GRAPHIC) — 74KB
- celz_def14aimg11.jpg (GRAPHIC) — 80KB
- celz_def14aimg12.jpg (GRAPHIC) — 56KB
- celz_def14aimg14.jpg (GRAPHIC) — 86KB
- celz_def14aimg16.jpg (GRAPHIC) — 117KB
- celz_def14aimg17.jpg (GRAPHIC) — 6KB
- celz_def14aimg8.jpg (GRAPHIC) — 6KB
- celz_def14aimg9.jpg (GRAPHIC) — 6KB
- 0001477932-24-006871.txt ( ) — 711KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 9 OTHER MATTERS 10 Table of Contents PROXY STATEMENT FOR SPECIAL MEETING OF STOCKHOLDERS To Be Held at 9:00 a.m. Pacific Standard Time on December 19, 2024 This proxy statement and the enclosed form of proxy are furnished in connection with the solicitation of proxies by our Board of Directors (the "Board" or "Board of Directors") for use at a special meeting of stockholders of Creative Medical Technology Holdings, Inc., a Nevada corporation, and any postponements, adjournments or continuations thereof (the "Special Meeting"). The Special Meeting will be held on December 19, 2024 at 9:00 a.m. Pacific Standard Time at 440 Stevens Avenue, Suite #200, Solana Beach, CA 92075. References in this Proxy Statement to "we," "us," "our," the "Company" or "Creative Medical Technology Holdings" refer to Creative Medical Technology Holdings, Inc. The Notice of Internet Availability of Proxy Materials (the "Notice") containing instructions on how to access this Proxy Statement is first being mailed on or about November 4, 2024 to all stockholders entitled to vote at the Special Meeting. THE INFORMATION PROVIDED IN THE "QUESTION AND ANSWER" FORMAT BELOW IS FOR YOUR CONVENIENCE ONLY AND IS MERELY A SUMMARY OF THE INFORMATION CONTAINED IN THIS PROXY STATEMENT. YOU SHOULD READ THIS ENTIRE PROXY STATEMENT CAREFULLY. 1 Table of Contents QUESTIONS AND ANSWERS ABOUT THE PROXY MATERIALS AND OUR SPECIAL MEETING Q: Why did I receive a Notice of Internet Availability of Proxy Materials instead of a full set of proxy materials? A: In accordance with the rules of the Securities and Exchange Commission ("SEC"), we have elected to furnish our proxy materials, including this Proxy Statement, primarily via the Internet. The Notice containing instructions on how to access our proxy materials is first being mailed on or about November 4, 2024 to all stockholders entitled to vote at the Special Meeting. Stockh